HbA1c Testing Devices Market Size, Share & Trends Analysis Report By Type of Device (Point-of-care (POC) Testing Devices, Laboratory-based Testing Devices), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
HbA1c Testing Devices Market Growth & Trends
The global HbA1c testing devices market size is anticipated to reach USD 3.15 billion by 2030, growing at a CAGR of 6.48% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for HbA1c testing devices is witnessing significant growth, driven by the rising prevalence of diabetes and the demand for accurate and efficient monitoring solutions. According to the CDC, in 2021, 38.4 million Americans, or 11.6% of the population, had diabetes. This includes 2 million Americans with type 1 diabetes, approximately 304,000 of whom are children and adolescents. The report also highlights that 1.2 million Americans are diagnosed with diabetes annually, underscoring the persistent need for diabetes care and management. HbA1c testing plays a crucial role in diabetes management by providing valuable insights into long-term blood sugar control and assisting healthcare providers in optimizing patient treatment plans.
The importance of glycemic control and HbA1c testing devices drive market growth by increasing demand for accurate monitoring tools, fostering innovation, and expanding market reach, particularly in low- and middle-income countries. Inadequate control leads to complications, impacting patients' quality of life and healthcare costs. According to a study, the Diabetes Control and Complications Trial (DCCT) shows that strict glucose control reduces long-term complications, highlighting the cost-effectiveness of intensive treatment. In low- and middle-income countries (LMICs), owing to late diagnosis, glycemic control and patient education become crucial. This, in turn, propels the need for early diagnosis, systematic complication screening, and timely treatment intensification to lower costs compared to inpatient care and treatment of complications.
The market is witnessing a notable shift towards Point-of-care (POC) testing devices, which offer rapid results, enabling timely interventions and personalized treatment plans. POC devices are gaining extensive popularity in homecare settings, enabling patients to monitor their HbA1c levels conveniently and effectively. This trend reflects the growing emphasis on patient-centric care and adoption of remote monitoring solutions in healthcare.
Key market players such as ARKRAY, Inc., Abbott Laboratories, Chek, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Inc., Trivitron Healthcare, EKF Diagnostics, and Tosoh Corporation are at the forefront of innovation in HbA1c testing devices. These companies are constantly focusing on developing advanced technologies to enhance the accuracy, speed, and user-friendliness of HbA1c testing devices, catering to the evolving needs of healthcare professionals and patients. For instance, in August 2022 , DxGen Corp. and Precision Diabetes, Inc. partnered to launch Epithod AutoDx, an automatic point-of-care analyzer for diabetes tests, including HbA1c. With a user-friendly design, it enables rapid results in settings such as physician offices and clinics, addressing the growing demand for on-site testing amid the pandemic.
HbA1c Testing Devices Market Report Highlights
HbA1c Testing Devices Market Growth & Trends
The global HbA1c testing devices market size is anticipated to reach USD 3.15 billion by 2030, growing at a CAGR of 6.48% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for HbA1c testing devices is witnessing significant growth, driven by the rising prevalence of diabetes and the demand for accurate and efficient monitoring solutions. According to the CDC, in 2021, 38.4 million Americans, or 11.6% of the population, had diabetes. This includes 2 million Americans with type 1 diabetes, approximately 304,000 of whom are children and adolescents. The report also highlights that 1.2 million Americans are diagnosed with diabetes annually, underscoring the persistent need for diabetes care and management. HbA1c testing plays a crucial role in diabetes management by providing valuable insights into long-term blood sugar control and assisting healthcare providers in optimizing patient treatment plans.
The importance of glycemic control and HbA1c testing devices drive market growth by increasing demand for accurate monitoring tools, fostering innovation, and expanding market reach, particularly in low- and middle-income countries. Inadequate control leads to complications, impacting patients' quality of life and healthcare costs. According to a study, the Diabetes Control and Complications Trial (DCCT) shows that strict glucose control reduces long-term complications, highlighting the cost-effectiveness of intensive treatment. In low- and middle-income countries (LMICs), owing to late diagnosis, glycemic control and patient education become crucial. This, in turn, propels the need for early diagnosis, systematic complication screening, and timely treatment intensification to lower costs compared to inpatient care and treatment of complications.
The market is witnessing a notable shift towards Point-of-care (POC) testing devices, which offer rapid results, enabling timely interventions and personalized treatment plans. POC devices are gaining extensive popularity in homecare settings, enabling patients to monitor their HbA1c levels conveniently and effectively. This trend reflects the growing emphasis on patient-centric care and adoption of remote monitoring solutions in healthcare.
Key market players such as ARKRAY, Inc., Abbott Laboratories, Chek, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Inc., Trivitron Healthcare, EKF Diagnostics, and Tosoh Corporation are at the forefront of innovation in HbA1c testing devices. These companies are constantly focusing on developing advanced technologies to enhance the accuracy, speed, and user-friendliness of HbA1c testing devices, catering to the evolving needs of healthcare professionals and patients. For instance, in August 2022 , DxGen Corp. and Precision Diabetes, Inc. partnered to launch Epithod AutoDx, an automatic point-of-care analyzer for diabetes tests, including HbA1c. With a user-friendly design, it enables rapid results in settings such as physician offices and clinics, addressing the growing demand for on-site testing amid the pandemic.
HbA1c Testing Devices Market Report Highlights
- Point-of-care (POC) testing devices dominated the HbA1c type of device segment and are anticipated to grow at the fastest CAGR over the forecast period owing to their vital use for informed decision-making in diabetes management.
- Immunoassays dominated the technology segment attributed to rapid and simplified results associated with the technology.
- The hospitals and clinics end-use segment dominated the market in 2023, which is attributed to the well-equipped advanced technology and infrastructure available in hospitals and clinics to handle these devices effectively.
- North America dominated the HbA1c testing devices industry owing to factors such as advanced healthcare infrastructure, rising prevalence of target diseases, and favorable regulatory environment.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type of Device
1.2.2. Technology
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of device
2.2.2. Technology outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. HBA1C TESTING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of diabetes
3.2.1.2. Technological advancement
3.2.1.3. Development of novel testing methodologies.
3.2.2. Market restraint analysis
3.2.2.1. High cost of devices
3.2.2.2. Stringent regulatory policies
3.3. HbA1c Testing Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
3.3.4. Volume Analysis (Laboratory-based Testing Devices)
CHAPTER 4. HBA1C TESTING DEVICES MARKET: TYPE OF DEVICE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global HbA1c Testing Devices Market Movement Analysis
4.3. Global HbA1c Testing Devices Market by Type of Device Outlook
4.4. Laboratory-based Testing Devices
4.4.1. Laboratory-based Testing Devices market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Point-of-care (POC) Testing Devices
4.5.1 Point-of-care (POC) testing devices market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. HBA1C TESTING DEVICES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global HbA1c Testing Devices Market Movement Analysis
5.3. Global HbA1c Testing Devices Market by Technology Outlook
5.4. Immunoassays
5.4.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Chromatography
5.5.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Enzymatic Assays
5.6.1. Enzymatic Assays market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Boronate Affinity Chromatography
5.7.1. Boronate Affinity Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. High-Performance Liquid Chromatography
5.8.1. High-Performance Liquid Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. HBA1C TESTING DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global HbA1c Testing Devices Market Movement Analysis
6.3. Global HbA1c Testing Devices Market by End-use Outlook
6.4. Hospitals & Clinics
6.4.1. Hospitals & Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Laboratories
6.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Homecare Settings
6.6.1. Homecare Settings market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. HBA1C TESTING DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY TYPE OF DEVICE, TECHNOLOGY, AND END-USE
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Bio-Rad Laboratories, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Abbott
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthineers AG
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. HUMAN
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Trinity Biotech
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Menarini Diagnostics s.r.l
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. SAKAE CO. LTD.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Ceragem Medisys Inc
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. SEKISUI MEDICAL CO., LTD.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type of Device
1.2.2. Technology
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of device
2.2.2. Technology outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. HBA1C TESTING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of diabetes
3.2.1.2. Technological advancement
3.2.1.3. Development of novel testing methodologies.
3.2.2. Market restraint analysis
3.2.2.1. High cost of devices
3.2.2.2. Stringent regulatory policies
3.3. HbA1c Testing Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
3.3.4. Volume Analysis (Laboratory-based Testing Devices)
CHAPTER 4. HBA1C TESTING DEVICES MARKET: TYPE OF DEVICE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global HbA1c Testing Devices Market Movement Analysis
4.3. Global HbA1c Testing Devices Market by Type of Device Outlook
4.4. Laboratory-based Testing Devices
4.4.1. Laboratory-based Testing Devices market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Point-of-care (POC) Testing Devices
4.5.1 Point-of-care (POC) testing devices market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. HBA1C TESTING DEVICES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global HbA1c Testing Devices Market Movement Analysis
5.3. Global HbA1c Testing Devices Market by Technology Outlook
5.4. Immunoassays
5.4.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Chromatography
5.5.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Enzymatic Assays
5.6.1. Enzymatic Assays market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Boronate Affinity Chromatography
5.7.1. Boronate Affinity Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. High-Performance Liquid Chromatography
5.8.1. High-Performance Liquid Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. HBA1C TESTING DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global HbA1c Testing Devices Market Movement Analysis
6.3. Global HbA1c Testing Devices Market by End-use Outlook
6.4. Hospitals & Clinics
6.4.1. Hospitals & Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Laboratories
6.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Homecare Settings
6.6.1. Homecare Settings market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. HBA1C TESTING DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY TYPE OF DEVICE, TECHNOLOGY, AND END-USE
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Bio-Rad Laboratories, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Abbott
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthineers AG
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. HUMAN
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Trinity Biotech
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Menarini Diagnostics s.r.l
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. SAKAE CO. LTD.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Ceragem Medisys Inc
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. SEKISUI MEDICAL CO., LTD.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 North America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 4 North America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 5 North America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 7 U.S. HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 10 Canada HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 13 Europe HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 14 Europe HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 17 Germany HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 20 UK HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 21 UK HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 23 France HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 24 France HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 26 Italy HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 29 Spain HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 32 Denmark HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 35 Sweden HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 38 Norway HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 39 Norway HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 42 Asia Pacific HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 43 Aisa Pacific HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 44 China HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 45 China HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 46 China HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 48 Japan HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 India HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 51 India HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 52 India HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 54 South Korea HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 55 South Korea HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 57 Australia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 58 Australia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 60 Thailand HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 61 Thailand HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 64 Latin America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 65 Latin America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 67 Brazil HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 70 Mexico HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 73 Argentina HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 76 MEA HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 77 MEA HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 78 MEA HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 80 South Africa HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 86 UAE HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 89 Kuwait HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 North America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 4 North America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 5 North America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 7 U.S. HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 10 Canada HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 13 Europe HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 14 Europe HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 17 Germany HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 20 UK HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 21 UK HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 23 France HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 24 France HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 26 Italy HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 29 Spain HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 32 Denmark HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 35 Sweden HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 38 Norway HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 39 Norway HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 42 Asia Pacific HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 43 Aisa Pacific HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 44 China HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 45 China HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 46 China HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 48 Japan HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 India HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 51 India HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 52 India HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 54 South Korea HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 55 South Korea HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 57 Australia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 58 Australia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 60 Thailand HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 61 Thailand HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 64 Latin America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 65 Latin America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 67 Brazil HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 70 Mexico HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 73 Argentina HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
Table 76 MEA HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 77 MEA HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 78 MEA HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 80 South Africa HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 86 UAE HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
Table 89 Kuwait HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 HbA1c testing devices market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 HbA1c testing devices market driver impact
Fig. 17 HbA1c testing devices market restraint impact
Fig. 18 HbA1c testing devices market: Type of device movement analysis
Fig. 19 HbA1c testing devices market: Type of device outlook and key takeaways
Fig. 20 Laboratory-based testing devices market estimates and forecast, 2018 - 2030
Fig. 21 Point-of-care (POC) testing devices estimates and forecast, 2018 - 2030
Fig. 22 HbA1c testing devices market: Technology movement analysis
Fig. 23 HbA1c testing devices market: Technology outlook and key takeaways
Fig. 24 Immunoassays market estimates and forecast, 2018 - 2030
Fig. 25 Chromatography estimates and forecast, 2018 - 2030
Fig. 26 Enzymatic Assays market estimates and forecast, 2018 - 2030
Fig. 27 Boronate Affinity Chromatography market estimates and forecast, 2018 - 2030
Fig. 28 High-Performance Liquid Chromatography market estimates and forecast, 2018 - 2030
Fig. 29 Others estimates and forecast, 2018 - 2030
Fig. 30 HbA1c testing devices market: End-use movement analysis
Fig. 31 HbA1c testing devices market: End-use outlook and key takeaways
Fig. 32 Hospitals & clinics market estimates and forecast, 2018 - 2030
Fig. 33 Diagnostic laboratories estimates and forecast, 2018 - 2030
Fig. 34 Homecare settings market estimates and forecast, 2018 - 2030
Fig. 35 Global HbA1c testing devices market: Regional movement analysis
Fig. 36 Global HbA1c testing devices market: Regional outlook and key takeaways
Fig. 37 Global HbA1c testing devices market share and leading players
Fig. 38 North America, by country
Fig. 39 North America
Fig. 40 North America market estimates and forecasts, 2018 - 2030
Fig. 41 U.S. key country dynamics
Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
Fig. 43 Canada key country dynamics
Fig. 44 Canada market estimates and forecasts, 2018 - 2030
Fig. 45 Europe
Fig. 46 Europe market estimates and forecasts, 2018 - 2030
Fig. 47 UK key country dynamics
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany key country dynamics
Fig. 50 Germany market estimates and forecasts, 2018 - 2030
Fig. 51 France key country dynamics
Fig. 52 France market estimates and forecasts, 2018 - 2030
Fig. 53 Italy key country dynamics
Fig. 54 Italy market estimates and forecasts, 2018 - 2030
Fig. 55 Spain key country dynamics
Fig. 56 Spain market estimates and forecasts, 2018 - 2030
Fig. 57 Denmark key country dynamics
Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
Fig. 59 Sweden key country dynamics
Fig. 60 Sweden market estimates and forecasts, 2018 - 2030
Fig. 61 Norway key country dynamics
Fig. 62 Norway market estimates and forecasts, 2018 - 2030
Fig. 63 Asia Pacific
Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 65 China key country dynamics
Fig. 66 China market estimates and forecasts, 2018 - 2030
Fig. 67 Japan key country dynamics
Fig. 68 Japan market estimates and forecasts, 2018 - 2030
Fig. 69 India key country dynamics
Fig. 70 India market estimates and forecasts, 2018 - 2030
Fig. 71 Thailand key country dynamics
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
Fig. 73 South Korea key country dynamics
Fig. 74 South Korea market estimates and forecasts, 2018 - 2030
Fig. 75 Australia key country dynamics
Fig. 76 Australia market estimates and forecasts, 2018 - 2030
Fig. 77 Latin America
Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
Fig. 79 Brazil key country dynamics
Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
Fig. 81 Mexico key country dynamics
Fig. 82 Mexico market estimates and forecasts, 2018 - 2030
Fig. 83 Argentina key country dynamics
Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
Fig. 85 Middle East and Africa
Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 87 South Africa key country dynamics
Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
Fig. 89 Saudi Arabia key country dynamics
Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 91 UAE key country dynamics
Fig. 92 UAE market estimates and forecasts, 2018 - 2030
Fig. 93 Kuwait key country dynamics
Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 95 Market share of key market players - HbA1c testing devices market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 HbA1c testing devices market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 HbA1c testing devices market driver impact
Fig. 17 HbA1c testing devices market restraint impact
Fig. 18 HbA1c testing devices market: Type of device movement analysis
Fig. 19 HbA1c testing devices market: Type of device outlook and key takeaways
Fig. 20 Laboratory-based testing devices market estimates and forecast, 2018 - 2030
Fig. 21 Point-of-care (POC) testing devices estimates and forecast, 2018 - 2030
Fig. 22 HbA1c testing devices market: Technology movement analysis
Fig. 23 HbA1c testing devices market: Technology outlook and key takeaways
Fig. 24 Immunoassays market estimates and forecast, 2018 - 2030
Fig. 25 Chromatography estimates and forecast, 2018 - 2030
Fig. 26 Enzymatic Assays market estimates and forecast, 2018 - 2030
Fig. 27 Boronate Affinity Chromatography market estimates and forecast, 2018 - 2030
Fig. 28 High-Performance Liquid Chromatography market estimates and forecast, 2018 - 2030
Fig. 29 Others estimates and forecast, 2018 - 2030
Fig. 30 HbA1c testing devices market: End-use movement analysis
Fig. 31 HbA1c testing devices market: End-use outlook and key takeaways
Fig. 32 Hospitals & clinics market estimates and forecast, 2018 - 2030
Fig. 33 Diagnostic laboratories estimates and forecast, 2018 - 2030
Fig. 34 Homecare settings market estimates and forecast, 2018 - 2030
Fig. 35 Global HbA1c testing devices market: Regional movement analysis
Fig. 36 Global HbA1c testing devices market: Regional outlook and key takeaways
Fig. 37 Global HbA1c testing devices market share and leading players
Fig. 38 North America, by country
Fig. 39 North America
Fig. 40 North America market estimates and forecasts, 2018 - 2030
Fig. 41 U.S. key country dynamics
Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
Fig. 43 Canada key country dynamics
Fig. 44 Canada market estimates and forecasts, 2018 - 2030
Fig. 45 Europe
Fig. 46 Europe market estimates and forecasts, 2018 - 2030
Fig. 47 UK key country dynamics
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany key country dynamics
Fig. 50 Germany market estimates and forecasts, 2018 - 2030
Fig. 51 France key country dynamics
Fig. 52 France market estimates and forecasts, 2018 - 2030
Fig. 53 Italy key country dynamics
Fig. 54 Italy market estimates and forecasts, 2018 - 2030
Fig. 55 Spain key country dynamics
Fig. 56 Spain market estimates and forecasts, 2018 - 2030
Fig. 57 Denmark key country dynamics
Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
Fig. 59 Sweden key country dynamics
Fig. 60 Sweden market estimates and forecasts, 2018 - 2030
Fig. 61 Norway key country dynamics
Fig. 62 Norway market estimates and forecasts, 2018 - 2030
Fig. 63 Asia Pacific
Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 65 China key country dynamics
Fig. 66 China market estimates and forecasts, 2018 - 2030
Fig. 67 Japan key country dynamics
Fig. 68 Japan market estimates and forecasts, 2018 - 2030
Fig. 69 India key country dynamics
Fig. 70 India market estimates and forecasts, 2018 - 2030
Fig. 71 Thailand key country dynamics
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
Fig. 73 South Korea key country dynamics
Fig. 74 South Korea market estimates and forecasts, 2018 - 2030
Fig. 75 Australia key country dynamics
Fig. 76 Australia market estimates and forecasts, 2018 - 2030
Fig. 77 Latin America
Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
Fig. 79 Brazil key country dynamics
Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
Fig. 81 Mexico key country dynamics
Fig. 82 Mexico market estimates and forecasts, 2018 - 2030
Fig. 83 Argentina key country dynamics
Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
Fig. 85 Middle East and Africa
Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 87 South Africa key country dynamics
Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
Fig. 89 Saudi Arabia key country dynamics
Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 91 UAE key country dynamics
Fig. 92 UAE market estimates and forecasts, 2018 - 2030
Fig. 93 Kuwait key country dynamics
Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 95 Market share of key market players - HbA1c testing devices market
